EG vs ELDN · P/E 17, rev $17.28B vs $209.6M cap
Everest Group Ltd (EG) versus Eledon Pharmaceuticals Inc (ELDN) — a side-by-side from cached financials, not a winner call.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Eledon Pharmaceuticals Inc (ELDN) is a biotechnology company listed on US.
Latest reported EG revenue for 2024-12-31 was $17.28B. Net income was $1.37B. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. EG currently screens at market cap $14.52B and trailing P/E 17.2.
ELDN does not have a complete income-statement cache yet.
EG currently screens at market cap $14.52B and trailing P/E 17.2. ELDN currently screens at market cap $209.6M.
Not investment advice. Open the EG and ELDN stock pages for the full models.
Not investment advice.